LivaNova PLC (LIVN) [Rocket]

In millions, except per share items	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21
	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q	10-Q
Revenues:
Neuromodulation			462.9	462.7	456.2	443.8	428.9
Other			41.4	55.9	76.9	128.0	127.5
Other			513.3	509.3	502.3	463.1	465.3
Total revenues			1,017.6	1,027.9	1,035.4	1,034.9	1,021.7
Revenue growth [+]			-0.4%
Neuromodulation			7.9%
Other			-67.5%
Cost of goods sold			297.2	319.6	332.0	364.9	374.2
Gross profit			720.4	708.4	703.3	670.0	647.5
Gross margin			70.8%	68.9%	67.9%	64.7%	63.4%
Selling, general and administrative [+]			468.5	474.7	471.9	462.3	457.3
Sales and marketing			344.0	350.3		347.5	342.5
General and administrative					124.4
Research and development			161.4	179.7	183.4	183.8	189.0
Equity in earnings			-0.1	-0.1	-0.1	-0.2	-0.2
Other operating expenses			10.8	42.2	51.5	98.3	100.9
EBITDA [+]			129.1	62.0	47.4	-20.3	-40.3
EBITDA growth			-420.4%
EBITDA margin			12.7%	6.0%	4.6%	-2.0%	-3.9%
Depreciation and amortization			49.5	50.4	51.1	54.3	59.7
EBIT [+]			79.6	11.6	-3.6	-74.6	-100.0
EBIT growth			-179.6%
EBIT margin			7.8%	1.1%	-0.3%	-7.2%	-9.8%
Interest expense, net [+]			39.5	41.6	49.7	58.7	62.2
Interest expense			39.9	42.1	50.2	59.4	62.7
Interest income					0.5	0.7
Other income (expense), net [+]			-62.1	-63.5	-73.9	-87.6	-37.4
Other					-0.8
Pre-tax income			-22.0	-93.5	-127.1	-422.4	-401.0
Income taxes			9.3	10.6	10.8	-9.9	-16.0
Tax rate			-42.1%	-11.4%
Net income			-31.4	-104.3	-138.1	-413.1	-385.7
Net margin			-3.1%	-10.1%	-13.3%	-39.9%	-37.7%

Basic EPS [+]			($0.60)	($2.04)	($2.76)	($8.34)	($7.90)
Growth			-92.4%
Diluted EPS [+]			($0.60)	($2.03)	($2.76)	($8.34)	($7.90)
Growth			-92.5%

Shares outstanding (basic) [+]			52.3	51.1	50.0	49.5	48.7
Growth			7.2%
Shares outstanding (diluted) [+]			52.6	51.3	50.0	49.5	48.7
Growth			8.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.